Related Experiment Video

Updated: Oct 3, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

beta-Thromboglobulin in patients with acute myocardial infarction according to the treatment

V Dymicka-Piekarska1, H Kemona, M Mantur

  • 1Department of Clinical Laboratory Diagnostics, Medical Academy of Białystok, Białystok, Poland.

Roczniki Akademii Medycznej W Bialymstoku (1995)
|January 10, 2002
PubMed

Insights

Platelet activation changes during myocardial infarction (MI). Thrombolytic therapy effectively inhibits platelet activation, as indicated by beta-thromboglobulin (beta-TG) levels, suggesting its therapeutic benefit in managing heart disease.

Area of Science:

  • Cardiology
  • Hematology
  • Biochemistry

Background:

  • Platelet hyperactivity is a known factor in heart disease, particularly acute myocardial infarction (MI).
  • Understanding platelet activation dynamics is crucial for effective MI treatment strategies.

Purpose of the Study:

  • To investigate the dynamic changes in beta-thromboglobulin (beta-TG) concentration in patients with MI.
  • To assess the influence of disease duration and treatment type on beta-TG levels.
  • To evaluate the impact of thrombolytic therapy on platelet activation markers.

Main Methods:

  • Study included 29 patients diagnosed with MI, divided into treatment groups.
  • Beta-thromboglobulin (beta-TG) concentration was measured using the immunoenzymatic method (ELISA).
  • Blood samples were collected on days 1, 3, 5, 8, and 11 post-infarction.

Main Results:

  • Significant alterations in platelet activation were observed throughout the course of myocardial infarction.
  • Treatment strategies demonstrably affected beta-TG concentrations.
  • Thrombolytic therapy was found to significantly inhibit platelet activation.

Conclusions:

  • Myocardial infarction is associated with dynamic changes in platelet activation.
  • The type of treatment administered influences beta-TG levels in MI patients.
  • Thrombolytic therapy shows promise in mitigating platelet activation during MI.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...